Measurements of external radiation of staff during and after bone scintigraphy in horses and evaluation of generated waste contamination

Size: px
Start display at page:

Download "Measurements of external radiation of staff during and after bone scintigraphy in horses and evaluation of generated waste contamination"

Transcription

1 Measurements of external radiation of staff during and after bone scintigraphy in horses and evaluation of generated waste contamination D. DIDIERLAURENT*, F. AUDIGIÉ and J.M. DENOIX CIRALE (Centre d Imagerie et de Recherches sur les Affections Locomotrices Equines) RN Goustranville, France * Corresponding author : ddidierlaurent@vet-alfort.fr SUMMARY Bone scintigraphy is a valuable technique in the diagnosis of lameness in horses. Dosimetry and measurements of waste contamination have been done to determine radiation hazards during bone scintigraphy exams in horses. For a single examination of an adult horse (500 kg bw) requiring GBq of technetium, dose rates have been detected according to different situations during the exam. In order to reduce radiation exposure of staff members, it is advisable to perform complementary imaging examination (radiography, ultrasonography) 24 hours after radiopharmaceutical injection, and to clean the stall 4 days after this injection. Keywords : bone scintigraphy - horse - technetium - safety. RÉSUMÉ Mesures de l exposition du personnel aux radiations pendant et après une scintigraphie osseuse chez le cheval et évaluation du risque dans l environnement. Par D. DIDIERLAURENT, F. AUDIGIÉ et J.M. DENOIX. La scintigraphie osseuse est une technique intéressante dans le diagnostic des pathologies locomotrices chez le cheval. Une dosimétrie et des mesures de contamination ont été réalisées pour déterminer l exposition aux rayonnements ionisants pendant une scintigraphie osseuse. Des débits d équivalents de dose ont été détectés selon les différentes situations rencontrées lors de l examen d un cheval adulte de 500 kg (injection de 5,027 GBq de diphosphonate marqué au technétium). Dans le but de réduire l exposition du personnel, il est recommandé de réaliser les examens complémentaires d imagerie (radiographie, échographie) 24 heures après l injection du radiopharmaceutique, et de curer les boxes 4 jours après cette injection. Mots-clés : scintigraphie osseuse - cheval - technétium - radioprotection. Introduction The purpose of this study was to determine the dose rate according to different situations during a bone scintigraphy in a 5 years french trotter (gelding kg body weight (bw) - height at the withers : 165 cm) injected with technetium (10 MBq.kg -1 ) associated to 3,3-diphosphono-1,2-propanedicarboxylique (DPD). In humans DPD was shown to present a urinary excretion lower than MPD (Methylene diphosphonate) and a better bone accumulation than MPD [2]. No reference is available in horses with this radiotracer. Therefore a radiation dosimetry was made to evaluate the time period required to wait before doing complementary imaging examination (radiography, ultrasonography), before returning the horse to the owner without radiation hazard, and before cleaning the stall. The duration of confinement of the horse in the center will be determined so that there will be no more detectable exposure rate for the public. Finally, the time period required to wait before cleaning the stall will be determined when no more contamination of biological waste can be detected, keeping in mind the ALARA (As Low As Reasonably Achievable) principle. Materials and methods A horse (500 kg bw) was injected with GBq (measured with a well counter - gas ionization chamber MEDI 404*) of technetium associated with DPD. Several measurements were performed. Gamma spectrometries with ECAM** gamma-camera without collimator were performed during the soft tissue phase (10 min after radiopharmaceutic injection), and during the bone phase (3 h after radiopharmaceutic injection) in the examination room. Measurements of environmental dose rates (EDR) (Hp 10) in µsv.h -1 during preparation of radiopharmaceutic behind leaded protections as shielded glove box (2.5 mm of lead), tungsten syringe shield (3 mm), protective floor screens (2 mm of lead), were done with a gas ionizing chamber (91 babyline***) and semi-conductor silicium detector (electronic dosimeter: Dosicard****) in contact with the horse during 3 days (hospitalization time). The detectors were in contact with the horse on the halter, proximolateral part of the left metatarsus, dorsal part of last left rib (region of the kidney) and medial aspect of the left stifle (region of the bladder). Measurements of activity of physiological fluid (60 ml)

2 312 DIDIERLAURENT (D.) AND COLLABORATORS and estimation of the activity ratio (Activity ratio = Total activity estimated / Total activity injected with Total activity estimated = Sample activity x Total physiological volume / Sample volume) were performed with a gas ionization chamber (well counter MEDI 404*). Blood samples were taken 30 min, 1h30, 3h, 4h, 5h, and 24h after radiopharmaceutic injection; the activity ratios were estimated assuming a total blood volume of 40 L. Similar calculations were performed for 60 ml urine sample taken 2h and 24h after radiopharmaceutic injection, assuming a total volume of 3 L for miction. These measurements give informations about biological period of radiotracer. Measurements of biological waste contamination were performed with a gamma-camera (acquisition time: 60 s, matrix: 128x128 pixels), and with a 91 babyline** in contact with a bucket of urine excreted 2 hours after injection. Measurements of shavings contamination 48h after radiopharmaceutic injection with the gamma-camera were also performed. These measurements allow the establishment of the time period required to wait before cleaning the stall. Results Gamma spectrum as measured 10 minutes and 3 hours after radiopharmaceutic injection are presented in Fig. 1. EDR (Hp 10) measured in contact with a 91 babyline are below 1 µsv.h -1 behind leaded protections (shielded glove box, tungsten syringe shield, protective floor screens...) even in the laboratory. The EDR during radiopharmaceutic injection is between 10 and 35 µsv.h -1 when the operators are within 1 meter of the horse. The EDR, within a 3 m radius, three hours after injection is between 1.5 and 8 µsv.h -1. Results obtained with semi-conductor silicium detectors in contact with the horse are presented in Table I. Measurements of physiological fluids activity are presented in Table II and Table III. Measurements of biological waste contamination performed on a urine bucket emitted 2 hours after radiopharmaceutic injection are illustrated in figure 2. The measurements performed on a container of shavings collected 48 hours after radiopharmaceutic injection are illustrated in figure 3. Discussion Spectrometries performed during soft tissue and bone phases are relatively similar. The photopeak over 140 kev and a large amount of scattered radiation between 40 and 125 kev was detected. These results showed the need of an electronic dosimetry with an adequate response between 40 and 140 kev, for the staff working close to the horse. The EDR (Hp 10) in the laboratory were very weak using scintigraphic protective equipments, i.e. shielded glove box, tungsten syringe shield, protective floor screen. They were higher during radiopharmaceutic injection and soft tissue phase (up to 200 µsv.h -1 in contact of regions such as kidneys). During the second phase of the exam (3 hours later), FIGURE 1. Gamma spectrum collected in the exam room. The rectangular area represent the gamma measured to perform a scintigram (centered on 140 kev +/-15%). * MEDI Linearity ± 1% between 1MBq and 200 GBq for γ between 35 kev and 3 MeV - Medisystem - Guyancourt - France ** Siemens AG Erlangen - Germany. *** Babyline 91 - Linearity < ± 10% between 1 and 10 µsv.h -1, < ± 7% between 10 and 100 µsv.h-1 - Eurysis Mesures - Saint Quentin - France **** Dosicard - Linearity < ± 15% between 60 and 1.25 MeV, < ±30% between 50 and 2 MeV - Eurysis Mesures - Saint Quentin - France

3 EXTERNAL RADIATION OF STAFF DURING AND AFTER BONE SCINTIGRAPHY IN HORSES 313 TABLE I. Dose equivalents debit (Hp 10) in µsv.h -1 and dose equivalents in µsv (dose equivalents are represented in bold) measured with dosicards placed on the horse. The dose equivalents debit are indicated with uncertainty of 15%. TABLE III. Activity measure (MBq) of a urine sample (60 ml) taken on a 3 L urine bucket. TABLE II. Activity measures of blood sample (60 ml) in MBq. dose rates were between 49 and 90 µsv.h -1. The dose rates measured the next day with semi-conductor silicium detectors on the horse showed debits between 2 to 7 µsv.h -1 depending on the region [3]. Therefore, the duration of 2 days hospitalization was necessary to reach zero values in contact with thoraco-lumbar region (kidneys), bladder, hindlimb and the head of the horse. Activity measurements of physiological fluids showed a quick decrease of the technetium blood concentration during the first 3 hours : technetium osseous fixation and kidneys elimination was very high at this stage. Therefore, radionuclide blood concentration disappeared quickly. Results showed an activity ratio of urinary concentration of approximately 10% (Table III) and a rapid decay of the radioelement in the sample. Two different biological periods were identified. The first one is very short and takes place during radiopharmaceutic bone accumulation (up to 2 hours after injection). During the second one, the radiopharmaceutic blood and urinary activity is low and reach zero 24 hours after injection as soon as the radiopharmaceutic is attached to the hydroxyapatite crystals on bone [2]. The law of radioactive decrease confirmed measurements of biological waste contamination. The regions of interest on the urine bucket showed that the activity decreased with physical half-life of technetium (6h) and measurements reached background noise 4 days later. The dose rates were 120 µsv.h -1 during the collection of urine 2 hours after injection, and 40 µsv.h -1 8 hours later. On shavings collected in the stall 48 hours after injection, the camera detected 2174 counts just after the collection, and reached background level 2 days later. Conclusion The different measurements showed that the dose rates were high during radiopharmaceutic injection and soft tissue phase. The basic radioprotection established permitted to limit dose equivalent, i.e. staying at distance from the injected horse; limiting the radiation time [4], avoiding the stall during the hours following radiopharmaceutic injection, performing maximum acquisitions without moving the horse;

4 314 DIDIERLAURENT (D.) AND COLLABORATORS FIGURE 2. Scintigraphic images of a urine bucket produced 2h after injection of radiopharmaceutic. Images are presented in chronological order : the date and time of images are indicated at the right bottom of each image. The last image represents background level detected by the camera (natural radiation). FIGURE 3. Scintigraphic images of a container of shavings collected 48 hours after radiopharmaceutic injection. Images are presented in chronological order : the date and time of images are indicated at the right bottom of each image. The third image represents background level detected by the camera (natural radiation).

5 EXTERNAL RADIATION OF STAFF DURING AND AFTER BONE SCINTIGRAPHY IN HORSES 315 immobilizing the horse with an appropriate tranquillizer; using leaded protections (lead aprons, shielded glove box, shielded syringe, protective floor screen...) to reduce average photon energy to personnel. The spectrum measurements demonstrated the need of using an electronic dosimeter that is capable of detection between 40 and 140 kev for workers monitoring. Twenty four hours after injection during further examination (radiography, ultrasonography), all the values detected at the surface of the horse were below 10 µsv.h -1. For hospitalization of horses, a two-day duration is sufficient to eliminate all hazards of external radiation of the public. Stall contamination came from the radioactive urine produced during the immediate hours after injection [2] as blood and urinary technetium concentration decreased very rapidly. The biologic period of the radiotracer was very short in the first 2 hours due to its renal clearance and then became longer due to its bone fixation. A period of 4 days is necessary to considerably limit the radiation caused by contaminated urine. Shavings contamination by faeces seems to be negligible in this study. To limit the hazard of contamination during exam and during the horse s hospitalization, latex gloves and clothes especially used for scintigraphy and overshoes are indispensable. References 1. DEVOUS M.D., TWARDOCK A.R. : Techniques and applications of nuclear medicine in the diagnosis of equine lameness. J. Am. Vet. Med. Ass., 1984, 184, SCHROTH H.J., HAUSINGER F., GARTH H., OBERHAUSEN E. : Comparison of the kinetics methylene-diphosphonate (MDP) and dicarboxypropan-diphosphonic acid (DPD), two radio-diagnostics for bone scintigraphy. Eur. J. Nucl. Med., 1984, 9, WHITELOCK RG. : Radiation hazard from horses undergoing scintigraphy using technetium-99m. Equine vet. J., 1997, 29, NEUWIRTH L, ROMINE C. : Ancillary equipment to increase and reduce radiation exposure in the equine nuclear medicine laboratory. Vet. Rad. & ultras., 2000, 5,

An investigation of the effect of ionising radiation on nurses and their patients during dialysis

An investigation of the effect of ionising radiation on nurses and their patients during dialysis International Scholars Journals African Journal of Nursing and Midwifery ISSN 2198-4638 Vol. 2 (7), pp. 548-552, September, 2015. Available online at www.internationalscholarsjournals.org International

More information

Palliative treatment of bone metastases with samarium-153

Palliative treatment of bone metastases with samarium-153 APPROVED BY: Z. Yang Page 1 of 5 Palliative treatment of bone metastases with samarium-153 Primary Indications: Rationale: To treat bone pain resulting from osteoblastic metastases as defined by bone scan.

More information

PHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5)

PHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5) PHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5) 1. (a) A radioisotope is an isotope that is unstable and will emit particles from the nucleus

More information

Radiation physics and radiation protection. University of Szeged Department of Nuclear Medicine

Radiation physics and radiation protection. University of Szeged Department of Nuclear Medicine Radiation physics and radiation protection University of Szeged Department of Nuclear Medicine Radiation doses to the population 1 Radiation doses to the population 2 Sources of radiation 1 Radiation we

More information

Therapy with radionuclides

Therapy with radionuclides Therapy with radionuclides Aim is to acheive interaction of radiotracer and tumor cells, with minimal iraddiation of surrounding tissue (absorbed dose only to tumor cells) Assoc. prof. V. Marković, MD,

More information

Radiation Protection in Laboratory work. Mats Isaksson, prof. Department of radiation physics, GU

Radiation Protection in Laboratory work. Mats Isaksson, prof. Department of radiation physics, GU Radiation Protection in Laboratory work Mats Isaksson, prof. Department of radiation physics, GU mats.isaksson@radfys.gu.se Fundamental principles (ICRP) Justification Optimisation Application of dose

More information

Basic radiation protection & radiobiology

Basic radiation protection & radiobiology Basic radiation protection & radiobiology By Dr. Mohsen Dashti Patient care & management 202 Wednesday, October 13, 2010 Ionizing radiation. Discussion issues Protecting the patient. Protecting the radiographer.

More information

Description of the consecutive stages (which took place from December 2002 to July 2003)

Description of the consecutive stages (which took place from December 2002 to July 2003) Radiation Protection Issues in a PET/CT Installation M. Coronado 1, R. Plaza 2, R. Couto 1, MD. Marin 1, C. Huerga 2, J. Coya 1, LM Martin Curto 1, M. Téllez de Cepeda 2 1 Servicio de Medicina Nuclear,

More information

Targeted Alpha Particle Therapy: Imaging, Dosimetry and Radiation Protection

Targeted Alpha Particle Therapy: Imaging, Dosimetry and Radiation Protection Targeted Alpha Particle Therapy: Imaging, Dosimetry and Radiation Protection Michael Lassmann Klinik und Poliklinik für Nuklearmedizin Direktor: Prof. Dr. A. Buck Targeted Therapy Basic Principles 2 Influence

More information

Radiation Exposure to Staff Using PET/CT Facility

Radiation Exposure to Staff Using PET/CT Facility Egyptian J. Nucl. Med., Vol. 8, No. 2, December 2013 1 Editorial Radiation Exposure to Staff Using PET/CT Facility Taalab, Kh; and Mohsen, Z Department of Nuclear Medicine, International Medical Center;

More information

Radiation Safety - Things You Need to Know

Radiation Safety - Things You Need to Know Radiation Safety - Things You Need to Know Michael Casey Ph.D. Phlebotomy Autumn Seminar 13 th October 2012 Radiation is a form of energy transport What is Radiation? It is caused by electrical disturbances

More information

KEYWORDS: nuclear medicine; gamma camera; radiopharmaceutical activities.

KEYWORDS: nuclear medicine; gamma camera; radiopharmaceutical activities. Radiopharmaceutical Activities Administered for Diagnostic Procedures in Nuclear Medicine in the First Six Months of the Gamma Camera Use in the Clinical Center of Montenegro - Podgorica Nevenka Antovic

More information

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs) Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs) Overview Indications The White Blood Cell Migration Study demonstrates the distribution

More information

Hand Dose in Nuclear Medicine Staff Members

Hand Dose in Nuclear Medicine Staff Members Hand Dose in Nuclear Medicine Staff Members T.M.Taha, Amany.Y.Shahein and R.Hassan* Radiation Protection Department, Nuclear Research Center, Atomic Energy Authority * National Cancer Institute, Cairo

More information

Radiation Dose Rates from Patients Administrated Radiopharmaceuticals Used for Brain Blood Flow Investigation.

Radiation Dose Rates from Patients Administrated Radiopharmaceuticals Used for Brain Blood Flow Investigation. Radiation Dose Rates from Patients Administrated Radiopharmaceuticals Used for Brain Blood Flow Investigation K.Ejiri 1, K. Minami 1, T.Sawai 3, M.Kato 3, K.Kikukawa 2, H.Toyama 2, T. Orito 1 and S. Koga

More information

Medical Physics 4 I3 Radiation in Medicine

Medical Physics 4 I3 Radiation in Medicine Name: Date: 1. This question is about radiation dosimetry. Medical Physics 4 I3 Radiation in Medicine Define exposure. A patient is injected with a gamma ray emitter. The radiation from the source creates

More information

Practice and Risk at Medical Facilities in Agency Operations

Practice and Risk at Medical Facilities in Agency Operations Practice and Risk at Medical Facilities in Agency Operations Igor Gusev Radiation Protection Unit IAEA International Atomic Energy Agency Outline What is medical radiation exposure? Radiation sources and

More information

Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin)

Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin) Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin) Overview Indications The successively demonstrates hepatic perfusion, hepatocyte clearance, hepatic

More information

Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide)

Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide) Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide) Overview Indications The Thyroid Uptake Measurement measures the metabolic activity

More information

Validation of the MEDRAD Intego PET Infusion System in the Clinical Nuclear Medicine Setting

Validation of the MEDRAD Intego PET Infusion System in the Clinical Nuclear Medicine Setting Validation of the MEDRAD Intego PET Infusion System in the Clinical Nuclear Medicine Setting Mark Weir BSc, MRT(N), CTIC(N) C. Vollrath BSc, CRPA(R) A. Bonnell OT Reg. (On.) CRPA Saskatoon - 2017 1 Disclaimer

More information

Click Here to Continue. Click Here to Return to Table of Contents

Click Here to Continue. Click Here to Return to Table of Contents TechneScan Gluceptate Package inserts are current as of January, 1997. Contact Professional Services, 1-888-744-1414, regarding possible revisions. Click Here to Continue Click Here to Return to Table

More information

45 Hr PET Registry Review Course

45 Hr PET Registry Review Course 45 HR PET/CT REGISTRY REVIEW COURSE Course Control Document Timothy K. Marshel, MBA, R.T. (R), (N)(CT)(MR)(NCT)(PET)(CNMT) The PET/CT Training Institute, Inc. SNMMI-TS 028600-028632 45hr CEH s Voice Credits

More information

RELIANT HOLDINGS LTD AND ITS AFFILIATES Safety Management System. Preparation: Safety Mgr Authority: CEO Issuing Dept: Safety Page: Page 1 of 5

RELIANT HOLDINGS LTD AND ITS AFFILIATES Safety Management System. Preparation: Safety Mgr Authority: CEO Issuing Dept: Safety Page: Page 1 of 5 Preparation: Safety Mgr Authority: CEO Issuing Dept: Safety Page: Page 1 of 5 Purpose The purpose of this program is to protect employees who may encounter ionizing radiation and its hazards while performing

More information

Theragnostics for bone metastases. Glenn Flux Royal Marsden Hospital & Institute of Cancer Research Sutton UK

Theragnostics for bone metastases. Glenn Flux Royal Marsden Hospital & Institute of Cancer Research Sutton UK Theragnostics for bone metastases Glenn Flux Royal Marsden Hospital & Institute of Cancer Research Sutton UK NPL 2015 Ra-223 Biodistribution & dosimetry Ra-223: 11.4 days half-life, range of 100 µm Six

More information

Martin Law, PhD, DABSNM, DABMP Physicist ic Radiology/QMH

Martin Law, PhD, DABSNM, DABMP Physicist ic Radiology/QMH A practical measure in personnel dose reduction for 90 Y-micropsheres liverdirected radioembolization: from radiology department to patient ward Martin Law, PhD, DABSNM, DABMP Physicist ic Radiology/QMH

More information

Radiation Safety Bone Densitometer

Radiation Safety Bone Densitometer Radiation Safety Bone Densitometer Outline I. State Regulations II. Fundamentals of Radiation Safety III. IV. i. Characteristics of x-ray radiation ii. Units of radiation dose iii. Biological effects iv.

More information

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics Neutron Interactions Part 2 George Starkschall, Ph.D. Department of Radiation Physics Neutron shielding Fast neutrons Slow down rapidly by scatter in hydrogenous materials, e.g., polyethylene, paraffin,

More information

Technical Considerations in Zevalin Radioimmunotherapy Kathy Thomas, MHA, CNMT City of Hope National Medical Center

Technical Considerations in Zevalin Radioimmunotherapy Kathy Thomas, MHA, CNMT City of Hope National Medical Center Technical Considerations in Zevalin Radioimmunotherapy Kathy Thomas, MHA, CNMT City of Hope National Medical Center Technical Considerations in Zevalin Radioimmunotherapy Objectives: Explain the technical

More information

RADIOACTIVITY & RADIATION CHARACTERISTICS

RADIOACTIVITY & RADIATION CHARACTERISTICS CEMP TRAINING SESSION 15-17 JULY 2013 RADIOACTIVITY & RADIATION CHARACTERISTICS Instructor: Gary M. Sandquist, PhD, CHP 2013 Training Session Slide 1 Occupational Dose Equivalent Limits General Public

More information

GLUCEPTATE. Technetium Tc 99m Gluceptate Kit DIAGNOSTIC DESCRIPTION

GLUCEPTATE. Technetium Tc 99m Gluceptate Kit DIAGNOSTIC DESCRIPTION 27194 0001E m TM GLUCEPTATE Technetium Tc 99m Gluceptate Kit DIAGNOSTIC DESCRIPTION The kit consists of reaction vials which contain the sterile, non-pyrogenic, nonradioactive ingredients necessary to

More information

Radiation Safety for New Medical Physics Graduate Students

Radiation Safety for New Medical Physics Graduate Students Radiation Safety for New Medical Physics Graduate Students John Vetter, PhD Medical Physics Department UW School of Medicine & Public Health Background and Purpose of This Training This is intended as

More information

Nuclear Medicine Diagnosis

Nuclear Medicine Diagnosis Anatomy : MRI Fonction : Nucl Med Nuclear Medicine Diagnosis Functional imaging = distribution of a (radio)- tracer in organs Each tracer is a SPY of a function, usually through a metabolic pathway flow

More information

Nuclear Medicine and PET. D. J. McMahon rev cewood

Nuclear Medicine and PET. D. J. McMahon rev cewood Nuclear Medicine and PET D. J. McMahon 150504 rev cewood 2018-02-15 Key Points Nuclear Medicine and PET: Imaging: Understand how Nuc Med & PET differ from Radiography & CT by the source of radiation. Be

More information

Atlas of Bone Scintigraphy in the Developing Paediatric Skeleton. The Normal Skeleton, Variants and Pitfalls

Atlas of Bone Scintigraphy in the Developing Paediatric Skeleton. The Normal Skeleton, Variants and Pitfalls Atlas of Bone Scintigraphy in the Developing Paediatric Skeleton The Normal Skeleton, Variants and Pitfalls FOREWORD Since the introduction of Technetium 99m polyphosphate in 1972 by Dr. M. Subramanian,

More information

Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)

Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP) Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP) Overview The Bone Mineral Study, with either Tc-99m-MDP or Tc-99m-HMDP, depicts the distribution

More information

Click Here to Continue. Click Here to Return to Table of Contents

Click Here to Continue. Click Here to Return to Table of Contents Hippuran I 131 Injection Package inserts are current as of January, 1997. Contact Professional Services, 1-888-744-1414, regarding possible revisions Click Here to Continue Click Here to Return to Table

More information

RADIATION MONITORING DEVICES R A D I A T I O N P R O T E C T I O N & B I O L O G Y - R H O D E S

RADIATION MONITORING DEVICES R A D I A T I O N P R O T E C T I O N & B I O L O G Y - R H O D E S RADIATION MONITORING DEVICES 10-526- 1 9 7 R A D I A T I O N P R O T E C T I O N & B I O L O G Y - R H O D E S DETECTION AND MEASUREMENT OF IONIZING RADIATION Dosimeter Dose-measuring device Two classifications:

More information

Training Course on Medical Preparedness and Response for a Nuclear or Radiological Emergency Pre- Test - BASIC

Training Course on Medical Preparedness and Response for a Nuclear or Radiological Emergency Pre- Test - BASIC Training Course on Medical Preparedness and Response for a Nuclear or Radiological Emergency Pre- Test - BASIC Name Date. (dd/mm/yyyy) Circle the correct answer(s). 1. Delayed effects of radiation exposure

More information

The mare was injected 7000 MBq Technetium 99 MDP and the bone phase examination was performed about three hours later.

The mare was injected 7000 MBq Technetium 99 MDP and the bone phase examination was performed about three hours later. 12 year old female used as Show Jumper History The mare was referred for scintigraphy of the front distal limbs. The referring veterinarian s complaint was chronic lameness located on the left front limb.

More information

Radiopharmaceuticals. Radionuclides in NM. Radionuclides NUCLEAR MEDICINE. Modes of radioactive decays DIAGNOSTIC THERAPY CHEMICAL COMPOUND

Radiopharmaceuticals. Radionuclides in NM. Radionuclides NUCLEAR MEDICINE. Modes of radioactive decays DIAGNOSTIC THERAPY CHEMICAL COMPOUND Univerzita Karlova v Praze - 1. Lékařská fakulta Radiation protection NUCLEAR MEDICINE Involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear medicine study

More information

PAGE 1 OF 5 HEALTH, SAFETY & ENVIROMENTAL MANUAL PROCEDURE: S560 Radiation Safety REV /14/2012

PAGE 1 OF 5 HEALTH, SAFETY & ENVIROMENTAL MANUAL PROCEDURE: S560 Radiation Safety REV /14/2012 PAGE 1 OF 5 RADIATION SAFETY PURPOSE: A wide usage of x-ray machines and isotopes for examination of steel plate fabricated and erected structures require a knowledge of the radiation hazard and the precautionary

More information

Radioactive sources in brachytherapy

Radioactive sources in brachytherapy Radioactive sources in brachytherapy Janez Burger Institute of Oncology, Department of Radiophysics, Brachytherapy Unit, Ljubljana, Slovenia Background. In modern brachytherapy, a great step forward was

More information

PHYTACIS. Kit for the preparation of technetium [ 99m Tc] phytate injection USER PACKAGE LEAFLET

PHYTACIS. Kit for the preparation of technetium [ 99m Tc] phytate injection USER PACKAGE LEAFLET PHYTACIS Kit for the preparation of technetium [ 99m Tc] phytate injection USER PACKAGE LEAFLET CIS bio international, member of IBA Molecular group of companies T1800nH (T1800- T1817) 01/2017 IDENTIFICATION

More information

Calibration of Radiation Instruments Used in Radiation Protection and Radiotherapy in Malaysia

Calibration of Radiation Instruments Used in Radiation Protection and Radiotherapy in Malaysia Abstract Calibration of Radiation Instruments Used in Radiation Protection and Radiotherapy in Malaysia Taiman Bin Kadni (taiman@mint.gov.my) Secondary Standard Dosimetry Laboratory (SSDL) Malaysian Institute

More information

Radiation Detection and Measurement

Radiation Detection and Measurement Radiation Detection and Measurement Range of charged particles (e.g.,!: µm; ": mm) Range of high energy photons (cm) Two main types of interactions of high energy photons Compton scatter Photoelectric

More information

Lecture 1. Lecture 1: The Different Modalities

Lecture 1. Lecture 1: The Different Modalities Lecture 1 Lecture 1: The Different Modalities In this Lecture Understanding the difference between the different modalities available Learn when to chose the appropriate modality Trust me, during the next

More information

DRAXIMAGE MDP-25 Kit for the Preparation of Technetium Tc 99m Medronate Injection. For Intravenous Use DIAGNOSTIC FOR SKELETAL IMAGING

DRAXIMAGE MDP-25 Kit for the Preparation of Technetium Tc 99m Medronate Injection. For Intravenous Use DIAGNOSTIC FOR SKELETAL IMAGING TECHNETIUM TC 99M MEDRONATE - medronic acid injection, powder, for solution Jubilant DraxImage Inc ---------- DRAXIMAGE MDP-25 Kit for the Preparation of Technetium Tc 99m Medronate Injection For Intravenous

More information

Upon successful completion of the course, the student should be competent in the following tasks:

Upon successful completion of the course, the student should be competent in the following tasks: COURSE INFORMATION Course Prefix/Number: RAD 201 Course Title: Radiation Biology Lab Hours/Week: 3.0 Credit Hours/Semester: 2.0 VA Statement/Distance Learning Attendance Textbook Information Student Code

More information

R: March, E D T P A. Kit for the Preparation of Technetium Tc 99m Pentetate Injection. DIAGNOSTIC - For Intravenous Use

R: March, E D T P A. Kit for the Preparation of Technetium Tc 99m Pentetate Injection. DIAGNOSTIC - For Intravenous Use R: March, 1998 27227 0002E m TM DESCRIPTION D T P A Kit for the Preparation of Technetium Tc 99m Pentetate Injection DIAGNOSTIC - For Intravenous Use Each kit consists of reaction vials which contain the

More information

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate) Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate) Overview Ga-68 dotatate binds to somatostatin receptors, with highest affinity for subtype 2 receptors (sstr2). It binds to cells that express

More information

Nuclear Medicine in the Diabetic Foot

Nuclear Medicine in the Diabetic Foot 26.11.2015, Uniklinik Balgrist Nuclear Medicine in the Diabetic Foot Martin Hüllner Nuklearmedizin und Neuroradiologie, USZ / UZH Outline A. Imaging modalities brief technical overview B. Nuclear medicine

More information

GALLIUM CITRATE Ga 67 INJECTION

GALLIUM CITRATE Ga 67 INJECTION 511945-0903 September 2003 USA Bristol-Myers Squibb Medical Imaging 331 Treble Cove Road N. Billerica, MA 01862 USA GALLIUM CITRATE Ga 67 INJECTION FOR DIAGNOSTIC USE DESCRIPTION: Gallium Citrate Ga 67

More information

The effect of the x-ray radiation for the organism Bionegatív effect

The effect of the x-ray radiation for the organism Bionegatív effect Radiation safety During each laboratory or diagnostic procedure, safety should be a primary objective. Radiography is no different. The veterinarian must establish and maintain a radiation safety program

More information

Utilize radiation safety principles to reduce the amount of radiation used to achieve desired clinical result.

Utilize radiation safety principles to reduce the amount of radiation used to achieve desired clinical result. Minimizing Dose Understand the importance and methods of pre-procedure patient assessment including a review of previous radiologic exams, disease processes and anatomical considerations that may increase

More information

General Nuclear Medicine

General Nuclear Medicine General Nuclear Medicine What is General Nuclear Medicine? What are some common uses of the procedure? How should I prepare? What does the equipment look like? How does the procedure work? How is the procedure

More information

Radiologic Units: What You Need to Know

Radiologic Units: What You Need to Know Radiologic Units: What You Need to Know TODD VAN AUKEN M.ED. RT (R)(MR) Agenda Greys, Sieverts, Coulombs per kg, & Becquerel's Conventional Units Other Concepts (LET, Q-Factor, Effective Dose, NCRP Report

More information

Sodium Iodide I 131 Solution. Click Here to Continue. Click Here to Return to Table of Contents

Sodium Iodide I 131 Solution. Click Here to Continue. Click Here to Return to Table of Contents Sodium Iodide I 131 Solution Package inserts are current as of January, 1997. Contact Professional Services, 1-888-744-1414, regarding possible revisions Click Here to Continue Click Here to Return to

More information

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique Nuclear Medicine - Unsealed radioactive preparations the tracer mixes with the patients body fluids on a molecular level (e.g. after intravenous injection) - 3 main fields: - In vitro : measuring concentrations

More information

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF) Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF) Overview Indication Sodium Fluoride F18 injection is a radioactive diagnostic agent for positron emission

More information

Section 7 ALARA Program

Section 7 ALARA Program Page 7-1 Section 7 ALARA Program Contents A. ALARA Principle... 7-2 1. Biological Basis... 7-2 2. Applied Practices... 7-3 3. Operational Dose Limits... 7-3 4. Collective Dose... 7-3 B. Radiation Safety

More information

Basics of nuclear medicine

Basics of nuclear medicine Basics of nuclear medicine Prof. dr. Davor Eterović Prof. dr. Vinko Marković Radioisotopes are used both in diagnostics and in therapy Diagnostics gamma emitters are used since gamma rays can penetrate

More information

Research Article Real-Time Scintigraphic Assessment of Intravenous Radium-223 Administration for Quality Control

Research Article Real-Time Scintigraphic Assessment of Intravenous Radium-223 Administration for Quality Control BioMed Research International Volume 2015, Article ID 324708, 6 pages http://dx.doi.org/10.1155/2015/324708 Research Article Real-Time Scintigraphic Assessment of Intravenous Radium-223 Administration

More information

Personnel internal radiation exposure to iodine-125 in a radioiodination laboratory: Exposure levels and trends

Personnel internal radiation exposure to iodine-125 in a radioiodination laboratory: Exposure levels and trends Iran. J. Radiat. Res., 2005; 3 (3): 117-122 Personnel internal radiation exposure to iodine-125 in a radioiodination laboratory: Exposure levels and trends F.Atabi 1, N.Alirezazadeh 2*, H. Garshasbi 2,

More information

Quantitative Theranostics in Nuclear Medicine

Quantitative Theranostics in Nuclear Medicine Quantitative Theranostics in Nuclear Medicine M. Lassmann Klinik und Poliklinik für Nuklearmedizin Direktor: Prof. Dr. A. Buck Contents What is Theranostics? Potential Targets Basic Principles of Quantitative

More information

Radiation protection in proton therapy

Radiation protection in proton therapy Radiation protection in proton therapy Pieternel van der Tol Medical Physicist - HollandPTC pvandertol@hollandptc.nl Marjan Dwarswaard René Bolt Marc-Jan van Goethem Lars Murrer Outline Introduction Interactions

More information

KEYWORDS: positron emission tomography, occupational dose, real time dose monitoring

KEYWORDS: positron emission tomography, occupational dose, real time dose monitoring A Real-Time Monitoring Study of the Personal Dose Received By Nuclear Medicine Technologists Administering 18 F-FDG in a High Patient Throughput PET Centre Anthony Wallace a1, Paul U a, Kevin Hickson a,

More information

Patient self-attenuation and technologist dose in positron emission tomography

Patient self-attenuation and technologist dose in positron emission tomography Patient self-attenuation and technologist dose in positron emission tomography Benjamin W. Zeff a and Michael V. Yester Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

More information

SUMMARY OF PRODUCT CHARACTERISTICS. for. BRIDATEC, kit for radiopharmaceutical preparation

SUMMARY OF PRODUCT CHARACTERISTICS. for. BRIDATEC, kit for radiopharmaceutical preparation February 9, 2010 SUMMARY OF PRODUCT CHARACTERISTICS for BRIDATEC, kit for radiopharmaceutical preparation 1. NAME OF THE MEDICINAL PRODUCT BRIDATEC 2. QUALITATIVE AND QUANTITATIVE COMPOSITION N-(3-bromo-2,4,6-trimethylphenylcarbamoyl

More information

MONITORING OF OCCUPATIONAL EXPOSURE AT NUCLEAR FACILITIES

MONITORING OF OCCUPATIONAL EXPOSURE AT NUCLEAR FACILITIES GUIDE YVL 7.10 / 29 JANUARY 2002 MONITORING OF OCCUPATIONAL EXPOSURE AT NUCLEAR FACILITIES 1 GENERAL 3 2 PROVISIONS OF THE RADIATION ACT AND DECREE 3 3 MONITORING OF RADIATION EXPOSURE 4 3.1 General requirements

More information

CURRENT STATUS AND POTENTIAL OF ALPHA-EMITTING RADIOPHARMACEUTICALS

CURRENT STATUS AND POTENTIAL OF ALPHA-EMITTING RADIOPHARMACEUTICALS CURRENT STATUS AND POTENTIAL OF ALPHA-EMITTING RADIOPHARMACEUTICALS Chaitanya Divgi, MD crdivgi@gmail.com NO DISCLOSURES Objectives Aware of the types of radionuclides with therapeutic potential. Familiar

More information

10 Years of Safe Operation at the Canadian Light Source A Radiation Safety Perspective

10 Years of Safe Operation at the Canadian Light Source A Radiation Safety Perspective 10 Years of Safe Operation at the Canadian Light Source A Radiation Safety Perspective G. Cubbon 1, A. Albert 1, P. Chowdhury 1, D. Street 1 1 Canadian Light Source Inc., 44 Innovation Boulevard, Saskatoon,

More information

Case 1: 79 yr-old woman with a lump in upper outer quadrant of left breast.

Case 1: 79 yr-old woman with a lump in upper outer quadrant of left breast. Case 1: 79 yr-old woman with a lump in upper outer quadrant of left breast. Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Relevant history 79-yr

More information

RADIATION MONITORING EXPERIMENT USING THERMOLUMINESCENT DOSIMETER FOR THE TR 19 CYCLOTRON AREA IN NUCLEAR RESEARCH INSTITUTE

RADIATION MONITORING EXPERIMENT USING THERMOLUMINESCENT DOSIMETER FOR THE TR 19 CYCLOTRON AREA IN NUCLEAR RESEARCH INSTITUTE RADIATION MONITORING EXPERIMENT USING THERMOLUMINESCENT DOSIMETER FOR THE TR 19 CYCLOTRON AREA IN NUCLEAR RESEARCH INSTITUTE A. STOCHIOIU, L. CRACIUN, F. MIHAI, I. TUDOR Horia Hulubei National Institute

More information

Determination of Beta Radiation Dose to the Thyroid Gland from the Ingestion of 131 I by Patients

Determination of Beta Radiation Dose to the Thyroid Gland from the Ingestion of 131 I by Patients American Journal of Environmental Protection 2016; 5(6): 168-178 http://www.sciencepublishinggroup.com/j/ajep doi: 10.11648/j.ajep.20160506.14 ISSN: 2328-5680 (Print); ISSN: 2328-5699 (Online) Determination

More information

Overview of Radiation Monitoring Laboratory Capabilities in Tunisia. Azza Hammou, CNRP, Tunis RMCC-8 Meeting, Amman Jordan JUNE 2013 CONTENT

Overview of Radiation Monitoring Laboratory Capabilities in Tunisia. Azza Hammou, CNRP, Tunis RMCC-8 Meeting, Amman Jordan JUNE 2013 CONTENT Overview of Radiation Monitoring Laboratory Capabilities in Tunisia Azza Hammou, CNRP, Tunis RMCC-8 Meeting, Amman Jordan 17-19 JUNE 2013 CONTENT TUNISIA RADIATION PROTECTION SYSTEM RADITION MONITORING

More information

The Study of 99m Tc-Aluminum Oxide Using for Sentinel Lymph Nodes Detection in Experiment

The Study of 99m Tc-Aluminum Oxide Using for Sentinel Lymph Nodes Detection in Experiment IOP Conference Series: Materials Science and Engineering PAPER OPEN ACCESS The Study of Tc-Aluminum Oxide Using for Sentinel Lymph Nodes Detection in Experiment To cite this article: A.A. Medvedeva et

More information

Now offering a Real-time dose measurement system featuring RaySafe i3. Powered by

Now offering a Real-time dose measurement system featuring RaySafe i3. Powered by Now offering a Real-time dose measurement system featuring RaySafe i3 Powered by Radiation exposure from medical procedures has increased dramatically in the United States since 1980 Interventional cardiologists

More information

CEREBRAL BLOOD FLOW AND METABOLISM

CEREBRAL BLOOD FLOW AND METABOLISM Supported by: HURO/0901/069/2.3.1 HU-RO-DOCS CEREBRAL BLOOD FLOW AND METABOLISM Part 3 Modern imaging methods SPECT, PET, nmri History of Nuclear Medicine Starts with the invention of the X-ray 1946: radioactive

More information

OPTION I TEST REVIEW

OPTION I TEST REVIEW IB PHYSICS 3 Name: Period: Date: DEVIL PHYSICS BADDEST CLASS ON CAMPUS OPTION I TEST REVIEW s2. This question is about defects of hearing. The graph below shows an audiogram for a person who has not been

More information

Code of Practice for Radiation Protection in Dentistry. Code of Practice For Radiation Protection in Dentistry

Code of Practice for Radiation Protection in Dentistry. Code of Practice For Radiation Protection in Dentistry Code of Practice for Radiation Protection in Dentistry Code of Practice For Radiation Protection in Dentistry 10 OCTOBER 2017 CONTENTS 1. INTRODUCTION... 3 1.0 CITATION... 3 1.1 BACKGROUND... 3 1.2 PURPOSE

More information

Bone Imaging Artifacts

Bone Imaging Artifacts Bone Imaging Artifacts Susan Weiss The Children's Memorial Hospital, Chicago, Illinois James J. Conway The Children's Memorial Hospital, and McGaw-Northwestern University Medical Center, Chicago, Illinois

More information

Introduction. Measurement of Secondary Radiation for Electron and Proton Accelerators. Introduction - Photons. Introduction - Neutrons.

Introduction. Measurement of Secondary Radiation for Electron and Proton Accelerators. Introduction - Photons. Introduction - Neutrons. Measurement of Secondary Radiation for Electron and Proton Accelerators D. Followill, Ph.D. Radiological Physics Center U. T. M. D. Anderson Cancer Center Introduction Patients undergoing radiation therapy

More information

The correlation between effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) with renal scintigraphy 99m Tc-DTPA study

The correlation between effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) with renal scintigraphy 99m Tc-DTPA study Journal of Physics: Conference Series PAPER OPEN ACCESS The correlation between effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) with renal scintigraphy Tc-DTPA study To cite this

More information

RADIATION SAFETY REFRESHER TRAINING FOR AUGUSTA UNIVERSITY USERS OF RADIOACTIVE MATERIAL

RADIATION SAFETY REFRESHER TRAINING FOR AUGUSTA UNIVERSITY USERS OF RADIOACTIVE MATERIAL RADIATION SAFETY REFRESHER TRAINING FOR AUGUSTA UNIVERSITY USERS OF RADIOACTIVE MATERIAL Environmental Health and Safety Division Course Content Radiation Safety Radiation Dose Limits and Dosimetry Postings

More information

RaySafe i3. Visualize your radiation exposure in real time.

RaySafe i3. Visualize your radiation exposure in real time. RaySafe i3 Visualize your radiation exposure in real time. Radiation Interventional Radiation exposure from medical procedures has increased dramatically in the United States since 1980. cardiologists

More information

PHYSICAL CHARACTERISTICS

PHYSICAL CHARACTERISTICS BRACCO DIAGNOSTICS L/4739/0 1 CHOLETEC Kit for the Preparation of Technetium Tc 99m Mebrofenin For Diagnostic Use DESCRIPTION Each reaction vial contains a nonradioactive, sterile, nonpyrogenic mixture

More information

A Snapshot of Current Practice of. Occupational Radiation Protection in Industrial Radiography

A Snapshot of Current Practice of. Occupational Radiation Protection in Industrial Radiography 18th World Conference on Non-destructive Testing, 16-20 April 2012, Durban, South Africa A Snapshot Current Practice Occupational Radiation Protection in Industrial Radiography Richard VAN SONSBEEK 1,

More information

Radiation Safety Manual

Radiation Safety Manual King Abdulaziz University Faculty of Dentistry Radiation Safety Manual FOR X-RAY EQUIPMENT OPERATORS October 2009 Radioactivity and Radiation All matter in our environment is made of atoms. Most atoms

More information

CLAUDIU PEŞTEAN 1,2, ELENA BĂRBUŞ 1,2, ANDRA PICIU 3,4, MARIA IULIA LARG 1,2, ALEXANDRINA SABO 1,5, CRISTINA MOISESCU-GOIA 1,5, DOINA PICIU 6,7

CLAUDIU PEŞTEAN 1,2, ELENA BĂRBUŞ 1,2, ANDRA PICIU 3,4, MARIA IULIA LARG 1,2, ALEXANDRINA SABO 1,5, CRISTINA MOISESCU-GOIA 1,5, DOINA PICIU 6,7 Oncology DOI: 10.15386/cjmed-637 SENTINEL LYMPH NODE SCINTIGRAPHY IN CUTANEOUS MELANOMA USING A PLANAR CALIBRATION PHANTOM FILLED WITH TC-99M PERTECHNETATE SOLUTION FOR BODY CONTOURING CLAUDIU PEŞTEAN

More information

Multiple Choice Identify the letter of the choice that best completes the statement or answers the question.

Multiple Choice Identify the letter of the choice that best completes the statement or answers the question. RA202 Rad protection class two True/False Indicate whether the sentence or statement is true or false. 1. Secondary radiation comes from scatter and leakage. 2. Grids are considered a protection device.

More information

Now offering a subscription based real-time dose measurement system featuring RaySafe i3. Powered by

Now offering a subscription based real-time dose measurement system featuring RaySafe i3. Powered by Now offering a subscription based real-time dose measurement system featuring RaySafe i3 Powered by Radiation exposure from medical procedures has increased dramatically in the United States since 1980

More information

EXPOSURE RATE IN HOT WAITING AREA OF SMALL BUT BUSY NUCLEAR MEDICINE DEPARTMENT: METER MATTERS

EXPOSURE RATE IN HOT WAITING AREA OF SMALL BUT BUSY NUCLEAR MEDICINE DEPARTMENT: METER MATTERS ORIGINAL ARTICLE EXPOSURE RATE IN HOT WAITING AREA OF SMALL BUT BUSY NUCLEAR MEDICINE DEPARTMENT: METER MATTERS Nosheen Fatima, 1 Maseeh uz Zaman, 2 M Khavi Iqbal, 1 Aitadal Rameez, 1 Qurratul Ain 1 1

More information

A Snapshot on Nuclear Cardiac Imaging

A Snapshot on Nuclear Cardiac Imaging Editorial A Snapshot on Nuclear Cardiac Imaging Khalil, M. Department of Physics, Faculty of Science, Helwan University. There is no doubt that nuclear medicine scanning devices are essential tool in the

More information

nuclear science and technology

nuclear science and technology EUROPEAN COMMISSION nuclear science and technology Evaluation of Individual Dosimetry in Mixed Neutron and Photon Radiation Fields (EVIDOS) Editor: Helmut Schuhmacher, Physikalisch-Technische Bundesanstalt

More information

Radiation Safety Information for Students in Courses given by the Nuclear Physics Group at KTH, Stockholm, Sweden

Radiation Safety Information for Students in Courses given by the Nuclear Physics Group at KTH, Stockholm, Sweden Radiation Safety Information for Students in Courses given by the Nuclear Physics Group at KTH, Stockholm, Sweden September 2006 The aim of this text is to explain some of the basic quantities and units

More information

Laboratory Safety 197/405. Types of Radiation 198/405

Laboratory Safety 197/405. Types of Radiation 198/405 Laboratory Safety 197/405 Types of Radiation 198/405 Particle Radiation Alpha He nucleus (heavy particle) +2 charge Internal hazard only Beta Electron -1 charge Internal and external hazard Neutron 199/405

More information

Radioactivity. Alpha particles (α) :

Radioactivity. Alpha particles (α) : Radioactivity It is the property of an element that causes it to emit radiation Discovered by Becquerel (1896) Radiation comes from the nucleus of the atom There are three types of radiation : alpha particles

More information

Brain Perfusion SPECT

Brain Perfusion SPECT APPROVED BY: Director of Radiology Page 1 of 5 Brain Perfusion SPECT Primary Indications: Brain perfusion SPECT is most commonly performed (1) to aid in identification of the epileptogenic focus in patients

More information

INDICATIONS AND USAGE

INDICATIONS AND USAGE 1. INDICATIONS AND USAGE a) Axumin is indicated for positron emission tomography (PET) in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following

More information